|
1
|
Shepard CW, Simard EP, Finelli L, et al:
Hepatitis B virus infection: epidemiology and vaccination.
Epidemiol Rev. 28:112–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robinson WS: Molecular events in the
pathogenesis of hepaDNA virus-associated hepatocellular carcinoma.
Annu Rev Med. 45:297–323. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yee JK: A liver-specific enhancer in the
core promoter region of human hepatitis B virus. Science.
246:658–661. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gitlin N: Hepatitis B: diagnosis,
prevention, and treatment. Clin Chem. 43:1500–1506. 1997.PubMed/NCBI
|
|
5
|
Tang H, Oishi N, Kaneko S, et al:
Molecular functions and biological roles of hepatitis B virus X
protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang X, Liu Y, Zhang Q, et al: Hepatitis
B virus sensitizes hepatocytes to TRAIL-induced apoptosis through
Bax. J Immunol. 178:503–510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mukherji A, Janbandhu VC and Kumar V:
HBx-dependent cell cycle deregulation involves interaction with
cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochem J.
401:247–256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shan C, Xu F, Zhang S, et al: Hepatitis B
virus X protein promotes liver cell proliferation via a positive
cascade loop involving arachidonic acid metabolism and p-ERK1/2.
Cell Res. 20:563–575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stockl L, Berting A, Malkowski B, et al:
Integrity of c-Raf-1/MEK signal transduction cascade is essential
for hepatitis B virus gene expression. Oncogene. 22:2604–2610.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tarn C, Lee S, Hu Y, et al: Hepatitis B
virus X protein differentially activates RAS-RAF-MAPK and JNK
pathways in X-transforming versus non-transforming AML12
hepatocytes. J Biol Chem. 276:34671–34680. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YH and Yun Y: HBx protein of hepatitis
B virus activates Jak1-STAT signaling. J Biol Chem.
273:25510–25515. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bock CT, Toan NL, Koeberlein B, et al:
Subcellular mislocalization of mutant hepatitis B X proteins
contributes to modulation of STAT/SOCS signaling in hepatocellular
carcinoma. Intervirology. 51:432–443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cong YS, Yao YL, Yang WM, et al: The
hepatitis B virus X-associated protein, XAP3, is a protein kinase
C-binding protein. J Biol Chem. 272:16482–16489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kekulé AS, Lauer U, Weiss L, et al:
Hepatitis B virus transactivator HBx uses a tumor promoter
signaling pathway. Nature. 361:742–745. 1993.PubMed/NCBI
|
|
15
|
Diao J, Khine AA, Sarangi F, et al: X
protein of hepatitis B virus inhibits Fas-mediated apoptosis and is
associated with up-regulation of the SAPK/JNK pathway. J Biol Chem.
276:8328–8340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oh JC, Jeong DL, Kim IK, et al: Activation
of calcium signaling by hepatitis B virus-X protein in liver cells.
Exp Mol Med. 35:301–309. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Dong N, Yin L, et al: Hepatitis B
virus X protein upregulates survivin expression in hepatoma
tissues. J Med Virol. 77:374–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takada S, Shirakata Y, Kaneniwa N, et al:
Association of hepatitis B virus X protein with mitochondria causes
mitochondrial aggregation at the nuclear periphery, leading to cell
death. Oncogene. 18:6965–6973. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sherlock S, Fox RA, Niazi SP, et al:
Chronic liver disease and primary liver cell cancer with
hepatitis-associated (Australia) antigen in serum. Lancet.
1:1243–1247. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim CM, Koike K, Saito I, et al: HBx gene
of hepatitis B virus induces liver cancer in transgenic mice.
Nature. 351:317–320. 1991. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gottlob K, Pagano S, Levrero M, et al:
Hepatitis B virus X protein transcription activation domains are
neither required nor sufficient for cell transformation. Cancer
Res. 58:3566–3570. 1998.PubMed/NCBI
|
|
22
|
Miao J, Chen GG, Chun SY, et al: Hepatitis
B virus X protein induces apoptosis in hepatoma cells through
inhibiting Bcl-xL expression. Cancer Lett. 236:115–124. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chirillo P, Pagano S, Natoli G, et al: The
hepatitis B virus X gene induces p53-mediated programmed cell
death. Proc Natl Acad Sci USA. 94:8162–8167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shintani Y, Yotsuyanagi H, Moriya K, et
al: Induction of apoptosis after switch-on of the hepatitis B virus
X gene mediated by the Cre/loxP recombination system. J Gen Virol.
80:3257–3265. 1999.PubMed/NCBI
|
|
25
|
Su F and Schneider RJ: Hepatitis B virus
HBx protein sensitizes cells to apoptotic killing by tumor necrosis
factor alpha. Proc Natl Acad Sci USA. 94:8744–8749. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YI, Kang-Park S, Do SI, et al: The
hepatitis B virus-X protein activates a phosphatidylinositol
3-kinase-dependent survival signaling cascade. J Biol Chem.
276:16969–16977. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan J, Duan LX, Sun BS, et al: Hepatitis B
virus X protein protects against anti-Fas-mediated apoptosis in
human liver cells by inducing NF-kappa B. J Gen Virol. 82:171–182.
2001.PubMed/NCBI
|
|
28
|
Shih WL, Kuo ML, Chuang SE, et al:
Hepatitis B virus X protein inhibits transforming growth
factor-beta-induced apoptosis through the activation of
phosphatidylinositol 3-kinase pathway. J Biol Chem.
275:25858–25864. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu BK, Li CC, Chen HJ, et al: Blocking of
G1/S transition and cell death in the regenerating liver of
Hepatitis B virus X protein transgenic mice. Biochem Biophys Res
Commun. 340:916–928. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tralhao JG, Roudier J, Morosan S, et al:
Paracrine in vivo inhibitory effects of hepatitis B virus X protein
(HBx) on liver cell proliferation: An alternative mechanism of
HBx-related pathogenesis. Proc Natl Acad Sci USA. 99:6991–6996.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gearhart TL and Bouchard MJ: Replication
of the hepatitis B virus requires a calcium-dependent HBx-induced
G1 phase arrest of hepatocytes. Virology. 407:14–25. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jacqueline B, Fei S, Margherita D, et al:
Hepatitis B virus HBx protein induces transcription factor AP-1 by
activation of extracellular signal-regulated and c-Jun N-terminal
mitogen-activated protein kinases. J Virol. 70:4978–4985. 1996.
|
|
33
|
Nijhara R, Jana SS, Goswami SK, et al:
Sustained activation of mitogen-activated protein kinases and
activator protein 1 by the hepatitis B virus X protein in mouse
hepatocytes in vivo. J Virol. 75:10348–10358. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kong GY, Zhang JP, Zhang S, et al:
Hepatitis B virus X protein promotes hepatoma cell proliferation
via upregulation of MEKK2. Acta Pharmacol Sin. 32:1173–1180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Medigeshi GR, Lancaster AM, Hirsch AJ, et
al: West Nile virus infection activates the unfolded protein
response, leading to CHOP induction and apoptosis. J Virol.
81:10849–10860. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moenner M, Pluquet O, Bouchecareilh M, et
al: Integrated endoplasmic reticulum stress responses in cancer.
Cancer Res. 67:10631–10634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tamaki N, Hatano E, Taura K, et al: CHOP
deficiency attenuates cholestasis-induced liver fibrosis by
reduction of hepatocyte injury. Am J Physiol Gastrointest Liver
Physiol. 294:G498–G505. 2008. View Article : Google Scholar : PubMed/NCBI
|
